Who Paid My Doc
Pat Whitworth
Surgical Oncology Nashville, TN Medical Doctor
NPI 1144205519 CMS profile 1136114
2004 Hayes St Ste 310, Nashville, TN 37203
General payments
$61,599
Research payments
$0
Ownership & investment interest
$297,307
Research they led as principal investigator
$25,900
Through program year 2025, Pat Whitworth of Nashville, TN is reported in the CMS Open Payments database as having received $61,599 across 87 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $25,900 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $297,307 across 6 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 96th percentile of Surgical Oncology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
13 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $32 | 1 | |
| 2024 | General | $284 | 3 | |
| 2023 | General | $1,311 | 22 | |
| 2022 | General | $5,867 | 15 | |
| 2021 | General | $20,761 | 18 | |
| 2020 | General | $30,526 | 21 | |
| 2019 | General | $2,816 | 7 | |
| 2025 | Ownership | $12,563 | 1 | |
| 2024 | Ownership | $67,602 | 1 | |
| 2023 | Ownership | $67,602 | 1 | |
| 2022 | Ownership | $58,830 | 1 | |
| 2021 | Ownership | $45,355 | 1 | |
| 2020 | Ownership | $45,355 | 1 |
Beside peers
- Pat Whitworth
- Surgical Oncology median
- Middle half of Surgical Oncology
- National median
In program year 2025, general payments to Pat Whitworth were reported at $32. Among 1,137 Surgical Oncology profiles paid that year, the median was $288 and the middle half received between $118 and $1,346.
Show as a table
| Year | Pat Whitworth | Surgical Oncology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $2,816 | $236 | $86–$1,064 | $163 |
| 2020 | $30,526 | $130 | $47–$648 | $114 |
| 2021 | $20,761 | $160 | $53–$943 | $132 |
| 2022 | $5,867 | $199 | $76–$782 | $149 |
| 2023 | $1,311 | $246 | $95–$854 | $160 |
| 2024 | $284 | $271 | $106–$1,123 | $164 |
| 2025 | $32 | $288 | $118–$1,346 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 2 drugsPart D claims
157
Drug cost
$3,923
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Anastrozole | Generic | 109 | $2,546 | |
| Letrozole | Generic | 48 | $1,376 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.
Records
87 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Surgical Oncology in Tennessee
Related records
Surgical Oncology in Tennessee
Practitioners in the same specialty and state, ranked by reported value.
All Surgical Oncology
Everyone recorded under this specialty, nationwide.
Doctors in Tennessee
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.